TY - JOUR A1 - Adrián-Martínez, S. A1 - Ageron, M. A1 - Aharonian, F. A1 - Aiello, S. A1 - Albert, A. A1 - Ameli, F. A1 - Annasontzis, E. A1 - Andre, M. A1 - Androulakis, G. A1 - Anghinolfi, M. A1 - Anton, G. A1 - Ardid, M. A1 - Avgitas, T. A1 - Barbarino, G. A1 - Baret, B. A1 - Barrios-Martí, J. A1 - Belhorma, B. A1 - Belias, A. A1 - Berbee, A. A1 - van den Berg, A. A1 - Bertin, V. A1 - Beurthey, S. A1 - van Beeveren, V. A1 - Beverini, N. A1 - Biagi, S. A1 - Biagioni, A. A1 - Billault, M. A1 - Bondì, M. A1 - Bormuth, R. A1 - Bouhadef, B. A1 - Bourlis, G. A1 - Bourret, S. A1 - Boutonnet, C. A1 - Bouwhuis, M. A1 - Bozza, C. A1 - Bruijn, R. A1 - Brunner, J. A1 - Buis, E. A1 - Busto, J. A1 - Cacopardo, G. A1 - Caillat, L. A1 - Calmai, M. A1 - Calvo, D. A1 - Capone, A. A1 - Caramete, L. A1 - Cecchini, S. A1 - Celli, S. A1 - Champion, C. A1 - Cherkaoui El Moursli, R. A1 - Cherubini, S. A1 - Chiarusi, T. A1 - Circella, M. A1 - Classen, L. A1 - Cocimano, R. A1 - Coelho, J. A. B. A1 - Coleiro, A. A1 - Colonges, S. A1 - Coniglione, R. A1 - Cordelli, M. A1 - Cosquer, A. A1 - Coyle, P. A1 - Creusot, A. A1 - Cuttone, G. A1 - D'Amico, A. A1 - De Bonis, G. A1 - De Rosa, G. A1 - De Sio, C. A1 - Di Capua, F. A1 - Di Palma, I. A1 - Díaz García, A. F. A1 - Distefano, C. A1 - Donzaud, C. A1 - Dornic, D. A1 - Dorosti-Hasankiadeh, Q. A1 - Drakopoulou, E. A1 - Drouhin, D. A1 - Drury, L. A1 - Durocher, M. A1 - Eberl, T. A1 - Eichie, S. A1 - van Eijk, D. A1 - El Bojaddaini, I. A1 - El Khayati, N. A1 - Elsaesser, D. A1 - Enzenhöfer, A. A1 - Fassi, F. A1 - Favali, P. A1 - Fermani, P. A1 - Ferrara, G. A1 - Filippidis, C. A1 - Frascadore, G. A1 - Fusco, L. A. A1 - Gal, T. A1 - Galatà, S. A1 - Garufi, F. A1 - Gay, P. A1 - Gebyehu, M. A1 - Giordano, V. A1 - Gizani, N. A1 - Gracia, R. A1 - Graf, K. A1 - Grégoire, T. A1 - Grella, G. A1 - Habel, R. A1 - Hallmann, S. A1 - van Haren, H. A1 - Harissopulos, S. A1 - Heid, T. A1 - Heijboer, A. A1 - Heine, E. A1 - Henry, S. A1 - Hernández-Rey, J. J. A1 - Hevinga, M. A1 - Hofestädt, J. A1 - Hugon, C. M. F. A1 - Illuminati, G. A1 - James, C. W. A1 - Jansweijer, P. A1 - Jongen, M. A1 - de Jong, M. A1 - Kadler, M. A1 - Kalekin, O. A1 - Kappes, A. A1 - Katz, U. F. A1 - Keller, P. A1 - Kieft, G. A1 - Kießling, D. A1 - Koffeman, E. N. A1 - Kooijman, P. A1 - Kouchner, A. A1 - Kulikovskiy, V. A1 - Lahmann, R. A1 - Lamare, P. A1 - Leisos, A. A1 - Leonora, E. A1 - Lindsey Clark, M. A1 - Liolios, A. A1 - Llorenz Alvarez, C. D. A1 - Lo Presti, D. A1 - Löhner, H. A1 - Lonardo, A. A1 - Lotze, M. A1 - Loucatos, S. A1 - Maccioni, E. A1 - Mannheim, K. A1 - Margiotta, A. A1 - Marinelli, A. A1 - Mariş, O. A1 - Markou, C. A1 - Martínez-Mora, J. A. A1 - Martini, A. A1 - Mele, R. A1 - Melis, K. W. A1 - Michael, T. A1 - Migliozzi, P. A1 - Migneco, E. A1 - Mijakowski, P. A1 - Miraglia, A. A1 - Mollo, C. M. A1 - Mongelli, M. A1 - Morganti, M. A1 - Moussa, A. A1 - Musico, P. A1 - Musumeci, M. A1 - Navas, S. A1 - Nicoleau, C. A. A1 - Olcina, I. A1 - Olivetto, C. A1 - Orlando, A. A1 - Papaikonomou, A. A1 - Papaleo, R. A1 - Păvălaş, G. E. A1 - Peek, H. A1 - Pellegrino, C. A1 - Perrina, C. A1 - Pfutzner, M. A1 - Piattelli, P. A1 - Pikounis, K. A1 - Poma, G. E. A1 - Popa, V. A1 - Pradier, T. A1 - Pratolongo, F. A1 - Pühlhofer, G. A1 - Pulvirenti, S. A1 - Quinn, L. A1 - Racca, C. A1 - Raffaelli, F. A1 - Randazzo, N. A1 - Rapidis, P. A1 - Razis, P. A1 - Real, D. A1 - Resvanis, L. A1 - Reubelt, J. A1 - Riccobene, G. A1 - Rossi, C. A1 - Rovelli, A. A1 - Saldaña, M. A1 - Salvadori, I. A1 - Samtleben, D. F. E. A1 - Sánchez García, A. A1 - Sánchez Losa, A. A1 - Sanguineti, M. A1 - Santangelo, A. A1 - Santonocito, D. A1 - Sapienza, P. A1 - Schimmel, F. A1 - Schmelling, J. A1 - Sciacca, V. A1 - Sedita, M. A1 - Seitz, T. A1 - Sgura, I. A1 - Simeone, F. A1 - Siotis, I. A1 - Sipala, V. A1 - Spisso, B. A1 - Spurio, M. A1 - Stavropoulos, G. A1 - Steijger, J. A1 - Stellacci, S. M. A1 - Stransky, D. A1 - Taiuti, M. A1 - Tayalati, Y. A1 - Tézier, D. A1 - Theraube, S. A1 - Thompson, L. A1 - Timmer, P. A1 - Tönnis, C. A1 - Trasatti, L. A1 - Trovato, A. A1 - Tsirigotis, A. A1 - Tzamarias, S. A1 - Tzamariudaki, E. A1 - Vallage, B. A1 - Van Elewyk, V. A1 - Vermeulen, J. A1 - Vicini, P. A1 - Viola, S. A1 - Vivolo, D. A1 - Volkert, M. A1 - Voulgaris, G. A1 - Wiggers, L. A1 - Wilms, J. A1 - de Wolf, E. A1 - Zachariadou, K. A1 - Zornoza, J. D. A1 - Zúñiga, J. T1 - Letter of intent for KM3NeT 2.0 JF - Journal of Physics G-Nuclear and Particle Physics N2 - The main objectives of the KM3NeT Collaboration are (i) the discovery and subsequent observation of high-energy neutrino sources in the Universe and (ii) the determination of the mass hierarchy of neutrinos. These objectives are strongly motivated by two recent important discoveries, namely: (1) the high-energy astrophysical neutrino signal reported by IceCube and (2) the sizable contribution of electron neutrinos to the third neutrino mass eigenstate as reported by Daya Bay, Reno and others. To meet these objectives, the KM3NeT Collaboration plans to build a new Research Infrastructure consisting of a network of deep-sea neutrino telescopes in the Mediterranean Sea. A phased and distributed implementation is pursued which maximises the access to regional funds, the availability of human resources and the synergistic opportunities for the Earth and sea sciences community. Three suitable deep-sea sites are selected, namely off-shore Toulon (France), Capo Passero (Sicily, Italy) and Pylos (Peloponnese, Greece). The infrastructure will consist of three so-called building blocks. A building block comprises 115 strings, each string comprises 18 optical modules and each optical module comprises 31 photo-multiplier tubes. Each building block thus constitutes a three-dimensional array of photo sensors that can be used to detect the Cherenkov light produced by relativistic particles emerging from neutrino interactions. Two building blocks will be sparsely configured to fully explore the IceCube signal with similar instrumented volume, different methodology, improved resolution and KW - neutrino astronomy KW - eutrino physics KW - deep sea neutrino telescope KW - neutrino mass hierarchy Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-188050 VL - 43 IS - 8 ER - TY - JOUR A1 - Bousquet, J. A1 - Anto, J. M. A1 - Akdis, M. A1 - Auffray, C. A1 - Keil, T. A1 - Momas, I. A1 - Postma, D. S. A1 - Valenta, R. A1 - Wickman, M. A1 - Cambon-Thomsen, A. A1 - Haahtela, T. A1 - Lambrecht, B. N. A1 - Lodrup Carlsen, K. C. A1 - Koppelman, G. H. A1 - Sunyer, J. A1 - Zuberbier, T. A1 - Annesi-Maesano, I. A1 - Arno, A. A1 - Bindslev-Jensen, C. A1 - De Carlo, G. A1 - Forastiere, F. A1 - Heinrich, J. A1 - Kowalski, M. L. A1 - Maier, D. A1 - Melen, E. A1 - Palkonen, S. A1 - Smit, H. A. A1 - Standl, M. A1 - Wright, J. A1 - Asarnoj, A. A1 - Benet, M. A1 - Ballardini, N. A1 - Garcia-Aymerich, J. A1 - Gehring, U. A1 - Guerra, S. A1 - Hohman, C. A1 - Kull, I. A1 - Lupinek, C. A1 - Pinart, M. A1 - Skrindo, I. A1 - Westman, M. A1 - Smagghe, D. A1 - Akdis, C. A1 - Albang, R. A1 - Anastasova, V. A1 - Anderson, N. A1 - Bachert, C. A1 - Ballereau, S. A1 - Ballester, F. A1 - Basagana, X. A1 - Bedbrook, A. A1 - Bergstrom, A. A1 - von Berg, A. A1 - Brunekreef, B. A1 - Burte, E. A1 - Carlsen, K.H. A1 - Chatzi, L. A1 - Coquet, J.M. A1 - Curin, M. A1 - Demoly, P. A1 - Eller, E. A1 - Fantini, M.P. A1 - Gerhard, B. A1 - Hammad, H. A1 - von Hertzen, L. A1 - Hovland, V. A1 - Jacquemin, B. A1 - Just, J. A1 - Keller, T. A1 - Kerkhof, M. A1 - Kiss, R. A1 - Kogevinas, M. A1 - Koletzko, S. A1 - Lau, S. A1 - Lehmann, I. A1 - Lemonnier, N. A1 - McEachan, R. A1 - Makela, M. A1 - Mestres, J. A1 - Minina, E. A1 - Mowinckel, P. A1 - Nadif, R. A1 - Nawijn, M. A1 - Oddie, S. A1 - Pellet, J. A1 - Pin, I. A1 - Porta, D. A1 - Rancière, F. A1 - Rial-Sebbag, A. A1 - Schuijs, M.J. A1 - Siroux, V. A1 - Tischer, C.G. A1 - Torrent, M. A1 - Varraso, R. A1 - De Vocht, J. A1 - Wenger, K. A1 - Wieser, S. A1 - Xu, C. T1 - Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story Mechanisms of the Development of ALLergy; EUFP7-CP-IP; Project No: 261357; 2010-2015 JF - Allergy N2 - MeDALL (Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015) has proposed an innovative approach to develop early indicators for the prediction, diagnosis, prevention and targets for therapy. MeDALL has linked epidemiological, clinical and basic research using a stepwise, large-scale and integrative approach: MeDALL data of precisely phenotyped children followed in 14 birth cohorts spread across Europe were combined with systems biology (omics, IgE measurement using microarrays) and environmental data. Multimorbidity in the same child is more common than expected by chance alone, suggesting that these diseases share causal mechanisms irrespective of IgE sensitization. IgE sensitization should be considered differently in monosensitized and polysensitized individuals. Allergic multimorbidities and IgE polysensitization are often associated with the persistence or severity of allergic diseases. Environmental exposures are relevant for the development of allergy-related diseases. To complement the population-based studies in children, MeDALL included mechanistic experimental animal studies and in vitro studies in humans. The integration of multimorbidities and polysensitization has resulted in a new classification framework of allergic diseases that could help to improve the understanding of genetic and epigenetic mechanisms of allergy as well as to better manage allergic diseases. Ethics and gender were considered. MeDALL has deployed translational activities within the EU agenda. KW - asthma KW - birth cohort KW - atopic-dermatitis KW - immune-responses KW - IgE KW - multimorbidity KW - polysensitization KW - rhinitis KW - chronic respiratory-diseases KW - childhood asthma KW - immunological reactivity KW - IgE sensitazion KW - immunoglobulin-e KW - integraed care Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-186858 VL - 71 IS - 11 ER - TY - JOUR A1 - Fröhlich, M. A1 - Pinart, M. A1 - Keller, T. A1 - Reich, A. A1 - Cabieses, B. A1 - Hohmann, C. A1 - Postma, D. S. A1 - Bousquet, J. A1 - Antó, J. M. A1 - Keil, T. A1 - Roll, S. T1 - Is there a sex-shift in prevalence of allergic rhinitis and comorbid asthma from childhood to adulthood? A meta-analysis JF - Clinical and Translational Allergy N2 - Background: Allergic rhinitis and asthma as single entities affect more boys than girls in childhood but more females in adulthood. However, it is unclear if this prevalence sex-shift also occurs in allergic rhinitis and concurrent asthma. Thus, our aim was to compare sex-specifc differences in the prevalence of coexisting allergic rhinitis and asthma in childhood, adolescence and adulthood. Methods: Post-hoc analysis of systematic review with meta-analysis concerning sex-specific prevalence of allergic rhinitis. Using random-effects meta-analysis, we assessed male–female ratios for coexisting allergic rhinitis and asthma in children (0–10 years), adolescents (11–17) and adults (> 17). Electronic searches were performed using MEDLINE and EMBASE for the time period 2000–2014. We included population-based observational studies, reporting coexisting allergic rhinitis and asthma as outcome stratifed by sex. We excluded non-original or non-population-based studies, studies with only male or female participants or selective patient collectives. Results: From a total of 6539 citations, 10 studies with a total of 93,483 participants met the inclusion criteria. The male–female ratios (95% CI) for coexisting allergic rhinitis and asthma were 1.65 (1.52; 1.78) in children (N = 6 studies), 0.61 (0.51; 0.72) in adolescents (N = 2) and 1.03 (0.79; 1.35) in adults (N = 2). Male–female ratios for allergic rhinitis only were 1.25 (1.19; 1.32, N = 5) in children, 0.80 (0.71; 0.89, N = 2) in adolescents and 0.98 (0.74; 1.30, N = 2) in adults, respectively. Conclusions: The prevalence of coexisting allergic rhinitis and asthma shows a clear male predominance in childhood and seems to switch to a female predominance in adolescents. This switch was less pronounced for allergic rhinitis only. KW - Medicine KW - Allergic rhinitis KW - Asthma KW - Multimorbidity KW - Prevalence KW - Systematic review Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-172508 VL - 7 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Schang, T. A1 - Keller, R. A1 - Müller-Ruchholtz, W. T1 - Reactivity of pancreas islet cells with antisera of known specificity N2 - No abstract available Y1 - 1984 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45466 ER - TY - JOUR A1 - Frank, Erik T. A1 - Kesner, Lucie A1 - Liberti, Joanito A1 - Helleu, Quentin A1 - LeBoeuf, Adria C. A1 - Dascalu, Andrei A1 - Sponsler, Douglas B. A1 - Azuma, Fumika A1 - Economo, Evan P. A1 - Waridel, Patrice A1 - Engel, Philipp A1 - Schmitt, Thomas A1 - Keller, Laurent T1 - Targeted treatment of injured nestmates with antimicrobial compounds in an ant society JF - Nature Communications N2 - Infected wounds pose a major mortality risk in animals. Injuries are common in the ant Megaponera analis, which raids pugnacious prey. Here we show that M. analis can determine when wounds are infected and treat them accordingly. By applying a variety of antimicrobial compounds and proteins secreted from the metapleural gland to infected wounds, workers reduce the mortality of infected individuals by 90%. Chemical analyses showed that wound infection is associated with specific changes in the cuticular hydrocarbon profile, thereby likely allowing nestmates to diagnose the infection state of injured individuals and apply the appropriate antimicrobial treatment. This study demonstrates that M. analis ant societies use antimicrobial compounds produced in the metapleural glands to treat infected wounds and reduce nestmate mortality. KW - animal behaviour KW - chemical ecology KW - entomology KW - microbial ecology KW - proteomics Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-358081 VL - 14 ER -